On November 6, 2025, President Trump announced agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to dramatically reduce GLP-1 prices and expand Medicare coverage for obesity
During this consultation, you will discuss your current challenges and goals with Rachel to determine if you are a good candidate for GLP-1 agonist medications
Eating smaller meals and slowing dose increases often reduces symptoms significantly
2019;3(3):CD007411
EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, et al
ALC is naturally synthesized by the brain, liver, and kidneys, but individuals may not produce enough to meet the bodys demands due to aging, genetics, or certain conditions.* When supplemented, ALC is readily absorbed and highly bioavailable